Skip to content

Bio-Rad Laboratories, Inc. BIO.B Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

Abbott logo
AbbottABT
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Charles River Laboratories logo
Charles River LaboratoriesCRL
Illumina logo
IlluminaILMN
Zoetis logo
ZoetisZTS

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts?
Bio-Rad Laboratories, Inc. (BIO.B) reported allowance for doubtful accounts of $4.9M in Q1 2026.
How has Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts changed year-over-year?
Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts decreased by 37.2% year-over-year, from $7.8M to $4.9M.
What is the long-term trend for Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts?
Over 5 years (2020 to 2025), Bio-Rad Laboratories, Inc.'s allowance for doubtful accounts has grown at a -22.6% compound annual growth rate (CAGR), from $19.81M to $5.5M.